Clifton, United Kingdom

Deborah Lynette Jackson


Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Clifton, GB (2007)
  • Stevenage, GB (2007)

Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Deborah Lynette Jackson

Introduction

Deborah Lynette Jackson is a prominent inventor based in Clifton, GB. She has made significant contributions to the field of antiviral agents, holding a total of 2 patents. Her work focuses on developing novel compounds for the treatment of viral infections, particularly Hepatitis C virus (HCV).

Latest Patents

One of her latest patents involves 1-acyl-pyrrolidine derivatives for the treatment of viral infections. This patent describes anti-viral agents of Formula (I), where various components represent different chemical structures. The patent also outlines processes for their preparation, pharmaceutical compositions comprising them, and methods of using them in HCV treatment. Another notable patent includes 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as HCV inhibitors, which are novel anti-viral agents designed to combat viral infections effectively.

Career Highlights

Deborah is currently associated with Glaxo Group Limited, where she continues to innovate in the pharmaceutical field. Her research has the potential to impact the treatment of viral infections significantly, showcasing her dedication to advancing medical science.

Collaborations

Throughout her career, Deborah has collaborated with esteemed colleagues, including David Haigh and Charles David Hartley. These partnerships have contributed to her success and the development of her innovative patents.

Conclusion

Deborah Lynette Jackson's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to antiviral research are paving the way for new treatments that could benefit many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…